Abstract
Autoimmune diseases are a collection of more than 80 individual diseases that are estimated to affect more than 3% of the U.S. population.1 Underlying this diverse group of diseases is one common pathology: the malfunction of the immune system, resulting in the destruction of self-tissue. The etiology of autoimmune diseases is thought to have both genetic and environmental contributions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223-243.
Levy C, Lindor KD. Management of primary biliary cirrhosis. Curr Treat Options Gastroenterol. 2003;6(6):493-498.
Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992;326(6):363-367.
Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF, Jr. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 1995;6(1):9-13.
Ytterberg SR. Infectious agents associated with myopathies. Curr Opin Rheumatol. 1996;8(6):507-513.
Caro I. Dermatomyositis. Semin Cutan Med Surg. 2001;20(1):38-45.
Kurzrock R, Cohen PR. Cutaneous paraneoplastic syndromes in solid tumors. Am J Med. 1995;99(6):662-671.
Peloro TM, Miller OF, III, Hahn TF, Newman ED. Juvenile dermatomyositis: a retrospective review of a 30-year experience. J Am Acad Dermatol. 2001;45(1):28-34.
Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20(3):387-408.
Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20(3):387-408.
Shirani Z, Kucenic MJ, Carroll CL, et al. Pruritus in adult dermatomyositis. Clin Exp Dermatol. 2004;29(3):273-276.
Hundley JL, Carroll CL, Lang W, et al. Cutaneous symptoms of dermatomyositis significantly impact patients’ quality of life. J Am Acad Dermatol. 2006;54(2):217-220.
Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 1996;27(1):15-19.
Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin. 2002;20(3):373-85, v.
Kapadia N, Haroon TS. Cutaneous manifestations of systemic lupus erythematosus: study from Lahore. Pakistan Int J Dermatol. 1996;35(6):408-409.
Goransson LG, Brun JG, Harboe E, Mellgren SI, Omdal R. Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Arch Neurol. 2006;63(10):1410-1413.
Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003;5(2):80-93.
Cepeda EJ, Reveille JD. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol. 2004;16(6):723-732.
Basu D, Reveille JD. Anti-scl-70. Autoimmunity. 2005;38(1):65-72.
Wallengren J, Akesson A, Scheja A, Sundler F. Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosis. Acta Derm Venereol. 1996;76(2):126-128.
Meyer O. Prognostic markers for systemic sclerosis. Joint Bone Spine. 2006;73(5):490-494.
Soy M, Piskin S. Cutaneous findings in patients with primary Sjogren’s syndrome. Clin Rheumatol. 2007;26(8):1350-1352.
Provost TT, Watson R. Cutaneous manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am. 1992;18(3):609-616.
Bernacchi E, Amato L, Parodi A, et al. Sjogren’s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol. 2004;22(1):55-62.
Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest. 2006;116(5):1159-1166.
Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;11(3):462-481.
Woldegiorgis S, Swerlick RA. Pemphigus in the southeastern United States. South Med J. 2001;94(7):694-698.
Caproni M, Feliciani C, Fuligni A, et al. Th2-like cytokine activity in dermatitis herpetiformis. Br J Dermatol. 1998;138(2):242-247.
Amerio P, Verdolini R, Giangiacomi M, et al. Expression of eotaxin, interleukin 13 and tumour necrosis factor-alpha in dermatitis herpetiformis. Br J Dermatol. 2000;143(5):974-978.
Engineer L, Bhol K, Ahmed AR. Pemphigoid gestationis: a review. Am J Obstet Gynecol. 2000;183(2):483-491.
Castro LA, Lundell RB, Krause PK, Gibson LE. Clinical experience in pemphigoid gestationis: report of 10 cases. J Am Acad Dermatol. 2006;55(5):823-828.
Chan LS, Traczyk T, Taylor TB, Eramo LR, Woodley DT, Zone JJ. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol. 1995;131(12):1432-1437.
Sitaru C. Experimental models of epidermolysis bullosa acquisita. Exp Dermatol. 2007;16(6):520-531.
Pai S, Marinkovich MP. Epidermolysis bullosa: new and emerging trends. Am J Clin Dermatol. 2002;3(6):371-380.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this chapter
Cite this chapter
Ishiuji, Y., Fleischer, A.B. (2010). Pruritus in Autoimmune Diseases. In: Misery, L., Ständer, S. (eds) Pruritus. Springer, London. https://doi.org/10.1007/978-1-84882-322-8_15
Download citation
DOI: https://doi.org/10.1007/978-1-84882-322-8_15
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-321-1
Online ISBN: 978-1-84882-322-8
eBook Packages: MedicineMedicine (R0)